alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 72, Number 4 (Monday, January 8, 2007)]
[Notices]
[Page 843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-10]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Office of the Secretary


List of Countries Requiring Cooperation With an International 
Boycott

    In order to comply with the mandate of section 999(a)93) of the 
Internal Revenue Code of 1986, the Department of the Treasury is 
publishing a current list of countries which require or may require 
participation in, or cooperation with, an international boycott (within 
the meaning of section 999(b)(3) of the Internal Revenue Code of 1986).
    On the basis of the best information currently available to the 
Department of the Treasury, the following countries require or may 
require participation in, or cooperation with, an international boycott 
(within the meaning of section 999(b)(3) of the Internal Revenue Code 
of 1986): Kuwait, Lebanon, Libya, Qatar, Saudi Arabia, Syria, United 
Arab Emirates, Yemen, Republic of.
    Iraq is not included in this list, but its status with respect to 
future lists remains under review by the Department of the Treasury.

    Dated: January 1, 2007.
Harry J. Hicks III,
International Tax Counsel (Tax Policy).
[FR Doc. 07-10 Filed 1-5-07; 8:45 am]
BILLING CODE 4180-25-M
<TABLE> <S> <C>


<ARTICLE>                     5



<S>                             <C>
<PERIOD-TYPE>                   year
<FISCAL-YEAR-END>               dec-31-1996
<PERIOD-END>                    dec-31-1996
<CASH>                                         145,845
<SECURITIES>                                   0
<RECEIVABLES>                                  2,526,816
<ALLOWANCES>                                   0
<INVENTORY>                                    5,170,661
<CURRENT-ASSETS>                               8,378,275
<PP&E>                                         3,638,300
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 15,481,627
<CURRENT-LIABILITIES>                          4,341,743
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       3,500
<OTHER-SE>                                     8,635,330
<TOTAL-LIABILITY-AND-EQUITY>                   15,481,627
<SALES>                                        26,139,828
<TOTAL-REVENUES>                               26,139,828
<CGS>                                          17,092,231
<TOTAL-COSTS>                                  8,522,647
<OTHER-EXPENSES>                               33,935
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             323,679
<INCOME-PRETAX>                                167,336
<INCOME-TAX>                                   18,999
<INCOME-CONTINUING>                            148,337
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   148,337
<EPS-PRIMARY>                                  .05
<EPS-DILUTED>                                  .05



</TABLE>
ufi-ex101_6.htm



Exhibit 10.1

 

FIRST AMENDMENT EMPLOYMENT AGREEMENT

 

THIS FIRST AMENDMENT (this “First Amendment”) effective this  9th day of June, 2020 (the “Effective Date”), is entered into by and between Edmund M. Ingle (“Executive”) and Unifi, Inc. (the “Employer”).

 

WHEREAS, Executive and the Employer entered into an Employment Agreement dated as of April 16, 2020 (the “Employment Agreement”); and

 

WHEREAS, Executive and the Employer desire to enter into this First Amendment to accelerate the commencement date of Executive’s employment with the Employer.

 

NOW, THEREFORE, in consideration of the foregoing, the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.Amendment.  Section 1 of the Employment Agreement is deleted in its entirety and replaced with the following:


	
 
	
1.
	
Employment.  Subject to the terms and conditions of this Agreement, the Employer agrees to employ Executive, and Executive agrees to be employed by the Employer, as of June 15, 2020 (the “Start Date”), pursuant to the terms of this Agreement. 




2. Continuing Effect of Employment Agreement. Except as expressly or by necessary implication amended by this First Amendment, the Employment Agreement shall continue in full force and effect.

[Signatures follow on next page]




 



 

IN WITNESS WHEREOF, the Employer has caused this Agreement to be executed by its duly authorized officer, and Executive has hereunto signed this Agreement, as of the Effective Date.

“Employer”:

Unifi, Inc.

 


		
	
By:
	
/s/ ALBERT P. CAREY

	
Name:
	
Albert P. Carey

	
Title:
	
Executive Chairman




 

“Executive”:


	
	
/s/ EDMUND M. INGLE

	
Name:    Edmund M. Ingle

	
 




 

 

 

[signature page to First Amendment to Employment Agreement]
v055340_ex10-81 Page

 

 









 

v055340_ex10-82 Page

 









 

v055340_ex10-83 Page

 









 

v055340_ex10-84 Page

 









 

v055340_ex10-85 Page

 









 

v055340_ex10-86 Page

 









 

v055340_ex10-87 Page

 









 

v055340_ex10-88 Page

 









 

v055340_ex10-89 Page

 









 

v055340_ex10-810 Page

 









 

v055340_ex10-811 Page

 









 

v055340_ex10-812 Page

 









 

v055340_ex10-813 Page

 









 

v055340_ex10-814 Page

 









 

v055340_ex10-815 Page

 









 

v055340_ex10-816 Page

 









 

v055340_ex10-817 Page

 









 

v055340_ex10-818 Page

 









 

v055340_ex10-819 Page

 









 

v055340_ex10-8220 Page

 









 

v055340_ex10-8221 Page

 









 

v055340_ex10-8222 Page

 









 

 

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---
§ 94.6 Remedies. ( a ) If the failure of an Investigator to comply with an Institution's financial conflicts of interest policy or a financial conflict of interest management plan appears to have biased the design, conduct, or reporting of the PHS-funded research, the Institution shall promptly notify the PHS Awarding Component of the corrective action taken or to be taken. The PHS Awarding Component will consider the situation and, as necessary, take appropriate action, or refer the matter to the Institution for further action, which may include directions to the Institution on how to maintain appropriate objectivity in the PHS-funded research project.
( b ) The PHS Awarding Component and/or HHS may inquire at any time (before, during, or after award) into any Investigator disclosure of financial interests and the Institution's review of, and response to, such disclosure, regardless of whether or not the disclosure resulted in the Institution's determination of a financial conflict of interest. An Institution is required to submit, or permit on site review of, all records pertinent to compliance with this part. To the extent permitted by law, HHS will maintain the confidentiality of all records of financial interests. On the basis of its review of records or other information that may be available, the PHS Awarding Component may decide that a particular financial conflict of interest will bias the objectivity of the PHS-funded research to such an extent that further corrective action is needed or that the Institution has not managed the financial conflict of interest in accordance with this part. The PHS Awarding Component may determine that issuance of a Stop Work Order by the Contracting Officer or other enforcement action is necessary until the matter is resolved.
( c ) In any case in which the HHS determines that a PHS-funded project of clinical research whose purpose is to evaluate the safety or effectiveness of a drug, medical device, or treatment has been designed, conducted, or reported by an Investigator with a financial conflict of interest that was not managed or reported by the Institution as required by this part, the Institution shall require the Investigator involved to disclose the financial conflict of interest in each public presentation of the results of the research and to request an addendum to previously published presentations.
§ 500.4 Suspension of attorneys. ( a ) The Commission may disqualify, or deny, temporarily or permanently, the privilege of appearing or practicing before it in any way to any person who is found after a hearing in the matter— ( 1 ) Not to possess the requisite qualifications to represent others before the Commission; or
( 2 ) To be lacking in character or integrity or to have engaged in unethical or improper professional conduct; or
( 3 ) To have violated sections 10 and 214 of the War Claims Act of 1948, as amended, section 4(f) of the International Claims Settlement Act of 1949, as amended, or section 1705(b)(6) of the National Defense Authorization Act for Fiscal Year 2017, Title XVII, Guam World War II Loyalty Recognition Act.
( b ) Contemptuous or contumacious conduct at any hearing will be ground for exclusion from that hearing and for summary suspension without a hearing for the duration of the hearing.
[66 FR 49844, Oct. 1, 2001, as amended at 82 FR 16126, Apr. 3, 2017]
Exhibit 32.1



CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report ofFirstar Exploration Corporation (the "Company") on Form 10-KSB for the year ended December 31, 2006 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Allen Collins, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) 	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) 	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated this 22nd day of March, 2007.



| | ALLEN COLLINS                                      
| | ---------------------------------------------------
| | Allen Collins                                      
| | Chief Executive Officer and Chief Financial Officer













---
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

_________ __ ______ __ _

NO. 09

- 13

- 00069

- CV

__________ __ _____ __ _

MILLET HARRISON JR., Appellant

V.

THE STATE OF TEXAS, Appellee

__________________________________________________________________

On Appeal from the 252nd District Court

Jefferson County, Texas

Trial Cause No. 94

- 66306

__________________________________________________________________

ORDER

Appellant filed a motion to recuse Justice David Gaultney on June 17, 2013.

I certify the matter to the entire court for decision. See Tex. R. App. P. 16.3(b).

ORDER ENTERED June 20 , 2013.

________________________________ DAVID GAULTNEY

Justice
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

[TEXT]
<ARTICLE> 5
<LEGEND>
Exhibit 27
Financial Data Schedule
 "This schedule contains summary financial information extracted
from December 31, 1997 10KSB and is qualified in its entirety by
reference to such financial statements."
</LEGEND>
       
<S>                               <C>
<PERIOD-START>                         JAN-01-1997
<PERIOD-TYPE>                     YEAR
<FISCAL-YEAR-END>                 DEC-31-1997
<PERIOD-END>                      DEC-31-1997
<CASH>                            56,541
<SECURITIES>                      0
<RECEIVABLES>                     175,226
<ALLOWANCES>                      0
<INVENTORY>                       14,193,063
<CURRENT-ASSETS>                  231,767
<PP&E>                            46,437
<DEPRECIATION>                         (1,016,660)
<TOTAL-ASSETS>                         13,454,607
<CURRENT-LIABILITIES>             6,207
<BONDS>                           16,300
<PREFERRED-MANDATORY>             0    
<PREFERRED>                       1,212
<COMMON>                          47,034
<OTHER-SE>                        13,383,854
<TOTAL-LIABILITY-AND-EQUITY>      13,454,607
<SALES>                           0
<TOTAL-REVENUES>                  287,837
<CGS>                             0
<TOTAL-COSTS>                     452,147
<OTHER-EXPENSES>                  0
<LOSS-PROVISION>                  0
<INTEREST-EXPENSE>                0
<INCOME-PRETAX>                   (164,310)
<INCOME-TAX>                      0
<INCOME-CONTINUING>                    (164,310)
<DISCONTINUED>                         0
<EXTRAORDINARY>                   0
<CHANGES>                              0
<NET-INCOME>                      (164,310)
<EPS-PRIMARY>                     0
<EPS-DILUTED>                     0
        

</TABLE>
#### § 213.27 Unsponsored written material.

Letters expressing views or urging action and other unsponsored written material regarding matters in issue in a hearing will be placed in the correspondence section of the docket of the proceeding. These data are not deemed part of the evidence or record in the hearing.
# CE2009271EN.01008001.xml

| 12.11.2009 | EN | Official Journal of the European Union | CE 271/80 |
| --- | --- | --- | --- |

12.11.2009

EN

Official Journal of the European Union

CE 271/80

---

Thursday 8 May 2008Excise duty on beer produced locally in Madeira *

P6_TA(2008)0188

European Parliament legislative resolution of 8 May 2008 on the proposal for a Council decision authorising Portugal to apply a reduced rate of excise duty on locally produced beer in the autonomous region of Madeira (COM(2007)0772 — C6-0012/2008 — 2007/0273(CNS))

2009/C 271 E/12

(Consultation procedure)

The European Parliament,

The European Parliament

having regard to the Commission proposal to the Council (COM(2007)0772),

having regard to Article 299(2) of the EC Treaty, pursuant to which the Council consulted Parliament (C6-0012/2008),

having regard to Rule 51 of its Rules of Procedure,

having regard to the report of the Committee on Regional Development and the opinion of the Committee on Agriculture and Rural Development (A6-0146/2008),

| 1. | Approves the Commission proposal; |
| --- | --- |

1.

Approves the Commission proposal;

| 2. | Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament; |
| --- | --- |

2.

Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament;

| 3. | Asks the Council to consult Parliament again if it intends to amend the Commission proposal substantially; |
| --- | --- |

3.

Asks the Council to consult Parliament again if it intends to amend the Commission proposal substantially;

| 4. | Instructs its President to forward its position to the Council and Commission. |
| --- | --- |

4.

Instructs its President to forward its position to the Council and Commission.

---
§ 73a.735-501 General provisions. ( a ) No restrictions are placed on ownership of diversified mutual funds.
( b ) An FDA employee, other than a control activity employee (defined in § 73a.735-502), may have financial interests: ( 1 ) In an organization whose FDA-regulated activities are an insignificant part of its total operations, i.e., no more than 10 percent of the organization's annual gross sales are in products regulated by FDA; or
( 2 ) In an organization whose FDA-regulated business activities are a significant part of its total business operations: *Provided,* That: ( i ) The holding is less than $5,000 (value or cost at time of initial reporting),
( ii ) The holding represents less than 1 percent of the total outstanding stock shares of that organization, and
( iii ) No more than 50 percent of the employee's total investment value is concentrated in organizations whose FDA-regulated business activities are a significant part of their business operations.
( c ) Notwithstanding the provisions of this part permitting employees to hold financial interests in organizations subject to FDA regulation, an employee holding such an interest shall not participate in an official matter whose outcome would have a direct and predictable effect on his financial interest. However, this prohibition is not applicable to: ( 1 ) Diversified mutual funds, which are exempted from 18 U.S.C. 208 by § 73.735-501(a) of this chapter.
( 2 ) Financial interests for which the Commissioner has in advance granted a written exception on the ground that the public interest would be served if a particular employee is allowed to participate in an official matter whose outcome may have a direct and predictable effect on the employee's financial interest. Such exemptions will be granted only in exceptional circumstances. Any determination to authorize such exceptions shall be made in accordance with 18 U.S.C. 208(b)(1) and documented for public inspection in accordance with § 73a.735-504.
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO. WR-89,851-02

EX PARTE SIMON BAZILLE, Applicant

ON APPLICATION FOR A WRIT OF HABEAS CORPUS

CAUSE NO. 1261252-B IN THE 180TH DISTRICT COURT

FROM HARRIS COUNTY

Per curiam. YEARY, J., filed a concurring opinion, which SLAUGHTER, J. joined.

O R D E R

Applicant was convicted of aggravated robberywith a deadlyweapon and sentenced to thirty

years’ imprisonment. The First Court of Appeals affirmed his conviction. Bazille v. State, No. 01-

11-00647-CR (Tex. App. — Houston [1 . Dist.], Feb. 20, 2014). Applicant filed this application for st

a writ of habeas corpus in the county of conviction, and the district clerk forwarded it to this Court. 

See TEX. CODE CRIM. PROC. art. 11.07.

Applicant contends that trial counsel was ineffective for the following: overriding his

decision to testify on his own behalf in both the guilt/innocence and punishment phases, and his

election to have the jury assess punishment rather than the court; failing to file a motion to allow him

to testify free from impeachment of prior conviction evidence; failing to file a motion to suppress
2

the in-court identification of Applicant; and failing to investigate and present mitigation witnesses. 

Applicant has alleged facts that, if true, might entitle him to relief. Strickland v. Washington, 466

U.S. 668 (1984). Accordingly, the record should be developed. The trial court is the appropriate

forum for findings of fact. TEX.CODECRIM.PROC. art. 11.07, § 3(d). The trial court shall order trial

counsel to respond to Applicant’s claim. In developing the record, the trial court may use anymeans

set out in Article 11.07, § 3(d). If the trial court elects to hold a hearing, it shall determine whether

Applicant is indigent. If Applicant is indigent and wants to be represented by counsel, the trial court

shall appoint counsel to represent him at the hearing. See TEX. CODE CRIM. PROC. art. 26.04. If

counsel is appointed or retained, the trial court shall immediately notify this Court of counsel’s

name.

The trial court shall make findings of fact and conclusions of law as to whethertrial counsel’s

performance was deficient and Applicant was prejudiced. The trial court may make any other

findings and conclusions that it deems appropriate in response to Applicant’s claims.

The trial court shall make findings of fact and conclusions of law within ninety days from

the date of this order. The district clerk shall then immediately forward to this Court the trial court’s

findings and conclusions and the record developed on remand, including, among other things,

affidavits, motions, objections, proposed findings and conclusions, orders, and transcripts from

hearings and depositions. See TEX.R.APP.P. 73.4(b)(4). Any extensions of time must be requested

by the trial court and obtained from this Court.

Filed: January 12, 2022

Do not publish
§ 91.33 Assurance of compliance and recipient assessment of age distinctions. ( a ) Each recipient of Federal financial assistance from HHS shall sign a written assurance as specified by HHS that it will comply with the Act and these regulations.
( b ) *Recipient assessment of age distinctions.* ( 1 ) As part of a compliance review under § 91.41 or complaint investigation under § 91.44, HHS may require a recipient employing the equivalent of 15 or more employees to complete a written self-evaluation, in a manner specified by the responsible Department official, of any age distinction imposed in its program or activity receiving Federal financial assistance from HHS to assess the recipient's compliance with the Act.
( 2 ) Whenever an assessment indicates a violation of the Act and the HHS regulations, the recipient shall take corrective action.
Exhibit 32.1



March 16, 2023



Via EDGAR



Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549



| | Re: | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
| | --- | ----------------------------------------------------------------------------------------------------------------------



Ladies and Gentlemen:



In connection with the Annual Report of MV Oil Trust
(the “Trust”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission
on the date hereof (the “Report”), the undersigned, not in its individual capacity but solely as the trustee of the Trust,
certifies pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to its knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Trust.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------



The above certification is furnished solely pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and is not being filed as part of the Report or as a separate
disclosure document.



| | The Bank Of New York Mellon Trust
    Company, N.a.
| | ---------------------------------------------------
| |                                                    
| | Trustee for MV Oil Trust                           
| |                                                    
| | By:                                                
| |